- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | FDA approves Revolution Medicines' first in class targeted therapy for metastatic pancreatic cancer | ||
| Do | Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth | ||
| Mi | BriaCell advances personalised skin cancer immunotherapy vaccine candidate | ||
| Mi | VML Health appoints Sus Misra as Executive Director, Data & Analytics | ||
| Di | Advanced Therapies Europe 2026 to put Europe's CGT competitiveness under the spotlight | ||
| Di | BeOne Medicines, BeOne Care Foundation and The Max Foundation renew partnership | ||
| Mo | LEO Pharma acquires rights for dersimelagon from Tanabe Pharma | ||
| Mo | LEO Pharma acquire rights for dersimelagon from Tanabe Pharma | ||
| Mo | Lucid Group appoints Eric Muller as CEO | ||
| 21.08. | 'Switchable' smart gel may pave the way for next-gen drug delivery and sensing tech | ||
| 21.08. | Creating a strong patent portfolio through constant communication | ||
| 20.08. | Merck and Moderna announce potential new vaccine for melanoma | ||
| 20.08. | Leading through complexity | ||
| 19.08. | NICE recommends axunio's Axhidrox cream for adults with severe hyperhydrosis | ||
| 19.08. | The Amazon reckoning: GLP-1s and the consumer lifestyle shift - why the molecule is no longer enough | ||
| 18.08. | Lupus - moving patient care beyond current therapies towards resetting the immune system | ||
| 18.08. | Pfizer and Valneva's application for Lyme disease vaccine candidate validated by EMA | ||
| 17.08. | NRG Therapeutics appoints Claus Sundgreen as Chief Medical Officer | ||
| 17.08. | Sandoz announces collaboration agreement with Shanghai Henlius Biotech | ||
| 17.08. | BeOne Medicines appoints Kandeepan Ganeshalingam as Vice President, Head of Medical Affairs, Europe | ||
| 14.08. | Bristol Myers Squibb announces new $2.3bn campus in the US | ||
| 14.08. | Richmond Pharmacology appoints Adam Hurd as Operations Director | ||
| 13.08. | FDA grants Fast Track status for peanut allergy immunotherapy | ||
| 13.08. | CNX Therapeutics appoints Lucy Ralph as Chief People and Transformation Officer | ||
| 12.08. | Ipsen's cabozantinib accepted by SMC for adults with advanced neuroendocrine tumours |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.